{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:49:55Z","timestamp":1756385395682},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Respir Med"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1007\/bf03257167","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T09:15:54Z","timestamp":1347095754000},"page":"403-408","source":"Crossref","is-referenced-by-count":10,"title":["Targeting Cysteinyl Leukotrienes in Patients with Rhinitis, Sinusitis and Paranasal Polyps"],"prefix":"10.1007","volume":"1","author":[{"given":"Steven M.","family":"Parnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,8]]},"reference":[{"key":"BF03257167_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","volume":"340","author":"JM Drazen","year":"1999","unstructured":"Drazen JM, Israel E, O\u2019Byrne P. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197\u2013206","journal-title":"N Engl J Med"},{"issue":"S2","key":"BF03257167_CR2","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1046\/j.1365-2222.1999.00019.x","volume":"29","author":"WW Busse","year":"1999","unstructured":"Busse WW, McGill KA, Horwitz RJ. Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 1999; 29(S2): S110\u20135","journal-title":"Clin Exp Allergy"},{"issue":"S2","key":"BF03257167_CR3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1378\/chest.111.2_Supplement.27S","volume":"111","author":"PM O\u2019Byrne","year":"1997","unstructured":"O\u2019Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest 1997; 111(S2): S27\u201334","journal-title":"Chest"},{"key":"BF03257167_CR4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1164\/ajrccm\/137.4.847","volume":"137","author":"N Ferreri","year":"1988","unstructured":"Ferreri N, Howland WC, Stevenson DD, et al. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988; 137: 847\u201354","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"BF03257167_CR5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/0003-4819-127-6-199709150-00009","volume":"127","author":"PM O\u2019Byrne","year":"1997","unstructured":"O\u2019Byrne PM, Israel E, Drazen JM. Antileukotrienes in the treatment of asthma. Ann Intern Med 1997; 127(6): 472\u201380","journal-title":"Ann Intern Med"},{"issue":"1","key":"BF03257167_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00063198-199801000-00005","volume":"4","author":"RA Tan","year":"1998","unstructured":"Tan RA. The role of antileukotrienes in asthma management. Curr Opin Pulm Med 1998; 4(1): 25\u201330","journal-title":"Curr Opin Pulm Med"},{"key":"BF03257167_CR7","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1164\/ajrccm.157.6.mar-5","volume":"157","author":"J Drazen","year":"1998","unstructured":"Drazen J. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am J Respir Crit Care Med 1998; 157: S233\u20137","journal-title":"Am J Respir Crit Care Med"},{"issue":"S2","key":"BF03257167_CR8","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1378\/chest.111.2_Supplement.52S","volume":"111","author":"NC Barnes","year":"1997","unstructured":"Barnes NC, Dejong B, Miyamoto T. Worldwide clinical experience with the first marketed leukotriene receptor antagonist. Chest 1997; 111(S2): S52\u201360","journal-title":"Chest"},{"issue":"6","key":"BF03257167_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-130-6-199903160-00005","volume":"130","author":"K Malmstrom","year":"1999","unstructured":"Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Ann Intern Med 1999; 130(6): 487\u201395","journal-title":"Ann Intern Med"},{"issue":"6","key":"BF03257167_CR10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/02770909609068181","volume":"33","author":"RA Nathan","year":"1996","unstructured":"Nathan RA. Anti-leukotriene agents: a new direction in asthma therapy. J Asthma 1996; 33(6): 353\u201366","journal-title":"J Asthma"},{"issue":"4","key":"BF03257167_CR11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0300-2977(98)00081-3","volume":"53","author":"Z Diamant","year":"1998","unstructured":"Diamant Z, Bel EH, Dekhuijzen PN. Anti-leukotriene therapy in asthma. Neth J Med 1998; 53(4): 176\u201389","journal-title":"Neth J Med"},{"issue":"1","key":"BF03257167_CR12","first-page":"17","volume":"24","author":"J Misson","year":"1999","unstructured":"Misson J, Clark W, Kendall MJ. Therapeutic advances: leukotriene antagonists for the treatment of asthma. J Clin Pharm 1999; 24(1): 17\u201322","journal-title":"J Clin Pharm"},{"issue":"15","key":"BF03257167_CR13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jama.279.15.1181","volume":"279","author":"B Knorr","year":"1998","unstructured":"Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- and 14-year old children: a randomized, double-blind trial. JAMA 1998; 279(15): 1181\u20136","journal-title":"JAMA"},{"key":"BF03257167_CR14","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1164\/ajrccm\/143.5_Pt_2.S91","volume":"143","author":"RM Naclerio","year":"1991","unstructured":"Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis 1991; 143: S91\u20135","journal-title":"Am Rev Respir Dis"},{"key":"BF03257167_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/019459989010200303","volume":"102","author":"BK Flowers","year":"1990","unstructured":"Flowers BK, Proud D, Kagey-Sobotka A, et al. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg 1990; 102: 219\u201324","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"25","key":"BF03257167_CR16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199012203232506","volume":"323","author":"HR Knapp","year":"1990","unstructured":"Knapp HR. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990; 323(25): 1745\u20138","journal-title":"N Engl J Med"},{"key":"BF03257167_CR17","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1164\/ajrccm.151.6.7767514","volume":"151","author":"AL Donnelly","year":"1995","unstructured":"Donnelly AL, Glass M, Minkwitz MC, et al. The leukotriene d4-receptor antagonist, ici 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995; 151: 1734\u20139","journal-title":"Am J Respir Crit Care Med"},{"key":"BF03257167_CR18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","volume":"157","author":"B Dahlen","year":"1998","unstructured":"Dahlen B. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Care Med 1998; 157: 1187\u201394","journal-title":"Am J Respir Care Med"},{"key":"BF03257167_CR19","first-page":"508","volume":"63","author":"LM Larocca","year":"1989","unstructured":"Larocca LM, Maggiano N, Capeli A, et al. Immunopathology of nasal polyps: an immunohistochemical approach. Ann Allergy 1989; 63: 508\u201351","journal-title":"Ann Allergy"},{"key":"BF03257167_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1288\/00005537-198702000-00009","volume":"97","author":"TTK Jung","year":"1987","unstructured":"Jung TTK, Juhn SK, Hwang D, et al. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987; 97: 184\u20138","journal-title":"Laryngoscope"},{"key":"BF03257167_CR21","first-page":"533","volume-title":"Prostaglandins Leukot Essent Fatty Acids","author":"S Pinto","year":"1997","unstructured":"Pinto S, Gallo O, Polli G, et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 1997; (6): 533\u20137"},{"issue":"6","key":"BF03257167_CR22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0196-0709(95)90077-2","volume":"16","author":"I Klapan","year":"1995","unstructured":"Klapan I, Culo F, Culig J, et al. Arachidonic acid metabolites and sinonasal polyposis: I. Possible prognostic value. Am J Otolaryngol 1995; 16(6): 396\u2013402","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"BF03257167_CR23","first-page":"166","volume":"34","author":"HW Baenkler","year":"1996","unstructured":"Baenkler HW, Schafer D, Hosemann W. Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhinology 1996; 34(3): 166\u201370","journal-title":"Rhinology"},{"key":"BF03257167_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.160.1.9808048","volume":"160","author":"C Picado","year":"1999","unstructured":"Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Care Med 1999; 160: 291\u20136","journal-title":"Am J Respir Care Med"},{"key":"BF03257167_CR25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/014556139907800818","volume":"72","author":"SO Ulualp","year":"1999","unstructured":"Ulualp SO, Sterman BM, Toohill RJ. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. American Rhinologic Society Spring Meeting; Palm Beach (FL) 1998. Ear Nose Throat J 1999; 72: 604\u201316","journal-title":"Ear Nose Throat J"},{"key":"BF03257167_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/014556130007900107","volume":"79","author":"SM Parnes","year":"1999","unstructured":"Parnes SM, Chuma AV. Acute effects of antileukotrienes on sinusitis and sinonasal polyposis 1999. Ear Nose Throat J 1999; 79: 18\u201325","journal-title":"Ear Nose Throat J"},{"issue":"9","key":"BF03257167_CR27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1365-2222.2001.01160.x","volume":"31","author":"S Ragab","year":"2001","unstructured":"Ragab S, Parikh A, Darby YC, et al. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001; 31(9): 1385\u201391","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"BF03257167_CR28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-2001-17832","volume":"80","author":"T Grundmann","year":"2001","unstructured":"Grundmann T, Topfner M. Treatment of ASS-associated polyposis (ASSAP) with a Cysteinyl leukotriene receptor antagonist: a prospective drug study on its antiinflammatory effects [in German]. Laryngorhinootologie 2001; 80(10): 576\u201382","journal-title":"Laryngorhinootologie"},{"issue":"5","key":"BF03257167_CR29","first-page":"336","volume":"20","author":"L Rienzo Di","year":"2000","unstructured":"Di Rienzo L, Artuso A, Cerqua N. Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome. Acta Otorhinolaryngol Ital 2000; 20(5): 336\u201342","journal-title":"Acta Otorhinolaryngol Ital"}],"container-title":["American Journal of Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03257167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03257167\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03257167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T01:25:03Z","timestamp":1714353903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03257167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["BF03257167"],"URL":"https:\/\/doi.org\/10.1007\/bf03257167","relation":{},"ISSN":["1175-6365"],"issn-type":[{"value":"1175-6365","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}